ENDURANT CAPITAL MANAGEMENT LP Horizon Therapeutics Public Limited Company Transaction History

ENDURANT CAPITAL MANAGEMENT LP portfolio value:

$0
portfolio value

ENDURANT CAPITAL MANAGEMENT LP quarter portfolio value change:

-22.40%
quarter

Horizon Therapeutics Public Limited Company 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -100.00% -8.45K shares -674K $61.89 0
Q2 2022 share Increase 0.00% 8.45K shares 674K $79.76 8.45K